Phase 1 Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with liver cancer (hepatocellular carcinoma).
- People who are planned to have surgery to remove part of the liver (hepatectomy).
- People whose liver is functioning at a healthy enough level, classified as Child-Pugh A (confirm with trial site).
- People who have had a specific protein called ITGA6 confirmed as highly active in their body before surgery (confirm with trial site).
- People aged between 18 and 80 years old, with a life expectancy of more than 6 months.
- People who are willing and able to sign a consent form agreeing to take part.
Who may not be able to join:
- People who have a known allergy to a substance called Cy7 (confirm with trial site).
- People who have taken part in another clinical trial within the past 3 months.
- People who have been found to have another type of cancer in addition to liver cancer.
- People whose heart, lungs, kidneys, or other major organs are not functioning well enough.
- People whose health would make it unsafe for them to undergo liver surgery.
- People whom the research team considers unsuitable for inclusion for any other reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhenhua Hu, Ph. D, Institute of Automation, Chinese Academy of Sciences
Phone: 13261798652
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
HCC lesions
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.